RESEARCH REPORT

Topiramate for the treatment of methamphetamine addiction: a multi-center placebo-controlled trial

  1. Ahmed Elkashef1,
  2. Roberta Kahn1,
  3. Elmer Yu2,
  4. Erin Iturriaga1,
  5. Shou-Hua Li1,
  6. Ann Anderson1,
  7. Nora Chiang1,
  8. Nassima Ait-Daoud3,
  9. David Weiss4,
  10. Frances McSherry4,
  11. Tracey Serpi4,
  12. Richard Rawson5,
  13. Mark Hrymoc5,
  14. Dennis Weis6,
  15. Michael McCann7,
  16. Tony Pham7,
  17. Christopher Stock8,
  18. Ruth Dickinson8,
  19. Jan Campbell9,
  20. Charles Gorodetzky9,
  21. William Haning10,
  22. Barry Carlton10,
  23. Joseph Mawhinney11,
  24. Ming D. Li3,
  25. Bankole A. Johnson3,*

Article first published online: 28 FEB 2012

DOI: 10.1111/j.1360-0443.2011.03771.x

Issue

Addiction

Addiction

Volume 107, Issue 7, pages 1297–1306, July 2012

Additional Information

How to Cite

Elkashef, A., Kahn, R., Yu, E., Iturriaga, E., Li, S.-H., Anderson, A., Chiang, N., Ait-Daoud, N., Weiss, D., McSherry, F., Serpi, T., Rawson, R., Hrymoc, M., Weis, D., McCann, M., Pham, T., Stock, C., Dickinson, R., Campbell, J., Gorodetzky, C., Haning, W., Carlton, B., Mawhinney, J., Li, M. D. and Johnson, B. A. (2012), Topiramate for the treatment of methamphetamine addiction: a multi-center placebo-controlled trial. Addiction, 107: 1297–1306. doi: 10.1111/j.1360-0443.2011.03771.x

Author Information

  1. 1

    National Institute on Drug Abuse, National Institutes of Health, Bethesda, MD, USA,

  2. 2

    Veterans Administration Medical Center, Philadelphia, PA, USA,

  3. 3

    Department of Psychiatry and Neurobehavioral Sciences, University of Virginia, Charlottesville, VA, USA,

  4. 4

    Department of Veterans Affairs Cooperative Studies Program Coordinating Center, Perry Point, MD, USA,

  5. 5

    UCLA Integrated Substance Abuse Programs, Los Angeles, CA, USA,

  6. 6

    Lutheran Hospital Office of Research, Des Moines, IA, USA,

  7. 7

    Matrix Institute on Addictions, Costa Mesa, CA, USA,

  8. 8

    Department of Veterans Affairs, Salt Lake City Health Care System, Salt Lake City, UT, USA,

  9. 9

    Department of Psychiatry, University of Missouri, Kansas City, MO, USA,

  10. 10

    Pacific Addiction Research Center, Honolulu, HI, USA

  11. 11

    South Bay Treatment Center, San Diego, CA, USA

*Bankole A. Johnson, Department of Psychiatry and Neurobehavioral Sciences, University of Virginia, PO Box 800623, Charlottesville, VA 22908-0623, USA. E-mail: bankolejohnson@virginia.edu

Publication History

  1. Issue published online: 6 JUN 2012
  2. Article first published online: 28 FEB 2012
  3. Accepted manuscript online: 16 DEC 2011 09:41AM EST
  4. Submitted 21 October 2010; initial review completed 30 December 2010; final version accepted 9 December 2011

SEARCH

SEARCH BY CITATION

ARTICLE TOOLS

View Full Article with Supporting Information (HTML) Get PDF (1064K)
FilenameFormatSizeDescription
add3771-sup-001-Apps1.pdf524KAppendix S1. NIDA Protocol Number: NIDA-MDS-Topiramate/meth-0001.

Please note: Wiley-Blackwell is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.

View Full Article with Supporting Information (HTML) Get PDF (1064K)